Compare MELI & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MELI | ELV |
|---|---|---|
| Founded | 1999 | 1944 |
| Country | Uruguay | United States |
| Employees | N/A | 97100 |
| Industry | Catalog/Specialty Distribution | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.0B | 86.6B |
| IPO Year | 2007 | 2001 |
| Metric | MELI | ELV |
|---|---|---|
| Price | $1,839.47 | $401.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 19 |
| Target Price | ★ $2,666.47 | $383.56 |
| AVG Volume (30 Days) | 427.2K | ★ 1.2M |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.83% |
| EPS Growth | ★ 4.54 | N/A |
| EPS | ★ 17.42 | 14.73 |
| Revenue | $28,893,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $36.23 | N/A |
| Revenue Next Year | $24.20 | $3.07 |
| P/E Ratio | $104.96 | ★ $27.03 |
| Revenue Growth | ★ 39.06 | 12.49 |
| 52 Week Low | $1,495.00 | $274.89 |
| 52 Week High | $2,548.50 | $436.24 |
| Indicator | MELI | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 56.65 |
| Support Level | $1,758.41 | $382.77 |
| Resistance Level | $1,899.50 | $408.00 |
| Average True Range (ATR) | 56.66 | 10.87 |
| MACD | -9.12 | 2.52 |
| Stochastic Oscillator | 40.80 | 92.88 |
MercadoLibre is the largest e-commerce marketplace in Latin America, with more than 120 million unique active buyers and 1 million active sellers at the end of 2025. The company is roughly split between its e-commerce business, which includes its fulfillment and advertising services, and its fintech segment, which comprises its rapidly expanding payment and digital wallet platform (Mercado Pago) and its lending business (Mercado Credito). While the company operates in 18 countries, its primary markets are Brazil, Argentina, and Mexico, which account for more than 95% of its revenue.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.